Bayer AG (OTCMKTS:BAYRY) has earned an average recommendation of “Hold” from the nine analysts that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and one has assigned a buy recommendation to the company.
Separately, ValuEngine upgraded Bayer from a “sell” rating to a “hold” rating in a report on Thursday, August 1st.
Shares of OTCMKTS BAYRY traded up $0.05 during mid-day trading on Thursday, reaching $15.69. The company had a trading volume of 398,199 shares, compared to its average volume of 572,030. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.92 and a current ratio of 1.37. The stock has a market capitalization of $58.52 billion, a PE ratio of 8.97, a PEG ratio of 0.81 and a beta of 1.09. The business has a 50-day moving average price of $16.52. Bayer has a 1-year low of $14.61 and a 1-year high of $28.02.
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.
Featured Story: What is the yield curve?
Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.